Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Does PTH offer additive value to ALP measurement in assessing CKD-MBD?

× No keyword cloud information.

49 in total

1. Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD.

Authors: Csaba P Kovesdy; Vitalie Ureche; Jun L Lu; Kamyar Kalantar-Zadeh
Journal: Nephrol Dial Transplant Date: 2010-03-17 Impact factor: 5.992

2. Influence of blood sampling site on intact parathyroid hormone concentrations in hemodialysis patients.

Authors: Carlo Vulpio; Maurizio Bossola; Dorina Speranza; Cecilia Zuppi; Giovanna Luciani; Enrico Di Stasio
Journal: Clin Chem Date: 2010-03 Impact factor: 8.327

3. Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis.

Authors: Connie M Rhee; Miklos Z Molnar; Wei Ling Lau; Vanessa Ravel; Csaba P Kovesdy; Rajnish Mehrotra; Kamyar Kalantar-Zadeh
Journal: Perit Dial Int Date: 2014-01-02 Impact factor: 1.756

4. Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization.

Authors: Matthew Abramowitz; Paul Muntner; Maria Coco; William Southern; Irwin Lotwin; Thomas H Hostetter; Michal L Melamed
Journal: Clin J Am Soc Nephrol Date: 2010-04-08 Impact factor: 8.237

5. Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis.

Authors: Clare Gardham; Paul E Stevens; Michael P Delaney; Marica LeRoux; Adrian Coleman; Edmund J Lamb
Journal: Clin J Am Soc Nephrol Date: 2010-05-24 Impact factor: 8.237

6. Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease.

Authors: P Manghat; W D Fraser; A S Wierzbicki; I Fogelman; D J Goldsmith; G Hampson
Journal: Osteoporos Int Date: 2009-12-09 Impact factor: 4.507

7. Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients.

Authors: Carol Moore; Jerry Yee; Hartmut Malluche; D Sudhaker Rao; Marie-Claude Monier-Faugere; Elizabeth Adams; Olufunmilola Daramola-Ogunwuyi; Hassan Fehmi; Saroj Bhat; Yahya Osman-Malik
Journal: Clin J Am Soc Nephrol Date: 2009-09 Impact factor: 8.237

8. Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality.

Authors: Marcello Tonelli; Gary Curhan; Marc Pfeffer; Frank Sacks; Ravi Thadhani; Michal L Melamed; Natasha Wiebe; Paul Muntner
Journal: Circulation Date: 2009-10-19 Impact factor: 29.690

9. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Authors:
Journal: Kidney Int Suppl Date: 2009-08 Impact factor: 10.545

10. The association between parathyroid hormone and mortality in dialysis patients is modified by wasting.

Authors: Christiane Drechsler; Vera Krane; Diana C Grootendorst; Eberhard Ritz; Karl Winkler; Winfried März; Friedo Dekker; Christoph Wanner
Journal: Nephrol Dial Transplant Date: 2009-05-27 Impact factor: 5.992

2 in total

Review 1. Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.

Authors: Mathias Haarhaus; Vincent Brandenburg; Kamyar Kalantar-Zadeh; Peter Stenvinkel; Per Magnusson
Journal: Nat Rev Nephrol Date: 2017-05-15 Impact factor: 28.314

2. Stabilization of serum alkaline phosphatase in hemodialysis patients by implementation of local chronic kidney disease-mineral bone disorder management strategy: A quality improvement study.

Authors: Kyubok Jin; Tae Hyun Ban; Ji Yong Jung; Ae Jin Kim; Yaerim Kim; So-Young Lee; Dong Ho Yang; Bum Soon Choi; Kook-Hwan Oh; Jieun Kim; Young Joo Kwon; Jong Wook Choi; Gheun-Ho Kim
Journal: Kidney Res Clin Pract Date: 2018-06-30

2 in total